A noninhibitory mutant of the caveolin-1 scaffolding domain enhances eNOS-derived NO synthesis and vasodilation in mice. - Wikidata - awgldk - TriplyDB

A noninhibitory mutant of the caveolin-1 scaffolding domain enhances eNOS-derived NO synthesis and vasodilation in mice.

A noninhibitory mutant of the caveolin-1 scaffolding domain enhances eNOS-derived NO synthesis and vasodilation in mice.

http://www.wikidata.org/entity/Q35187037

about

Post-translational regulation of endothelial nitric oxide synthase in vascular endothelium Nitrosation-dependent caveolin 1 phosphorylation, ubiquitination, and degradation and its association with idiopathic pulmonary arterial hypertension Interferon gamma receptor: the beginning of the journey Endocytic crosstalk: cavins, caveolins, and caveolae regulate clathrin-independent endocytosis Modulating Vascular Hemodynamics With an Alpha Globin Mimetic Peptide (HbαX).Endothelial nitric oxide synthase in the microcirculation.Regulation of cellular communication by signaling microdomains in the blood vessel wall.Structure-based reassessment of the caveolin signaling model: do caveolae regulate signaling through caveolin-protein interactions?Effects of simulated microgravity on human umbilical vein endothelial cell angiogenesis and role of the PI3K-Akt-eNOS signal pathway.Caveolar fatty acids and acylation of caveolin-1 Oxidative stress induces caveolin 1 degradation and impairs caveolae functions in skeletal muscle cells.Caveolae, caveolins, cavins, and endothelial cell function: new insights.Nitric oxide-dependent Src activation and resultant caveolin-1 phosphorylation promote eNOS/caveolin-1 binding and eNOS inhibition.Caveolin-1, caveolae, and glioblastoma Caveolin-1 in Cardiovascular Disease: A Double-Edged Sword.Caveolin as a potential drug target for cardiovascular protection.Differential regulation of cell functions by CSD peptide subdomains.Molecular control of nitric oxide synthesis through eNOS and caveolin-1 interaction regulates osteogenic differentiation of adipose-derived stem cells by modulation of Wnt/β-catenin signaling.Caveolae: A Role in Endothelial Inflammation and Mechanotransduction?An association of metabolic syndrome constellation with cellular membrane caveolae Membrane-mediated regulation of vascular identity.Peroxynitrite disrupts endothelial caveolae leading to eNOS uncoupling and diminished flow-mediated dilation in coronary arterioles of diabetic patients.Targeting endothelial dysfunction in vascular complications associated with diabetes.Cavin-1: caveolae-dependent signalling and cardiovascular disease.Uncoupling Caveolae From Intracellular Signaling In Vivo.Myocardial tissue caveolae.Are reactive oxygen species still the basis for diabetic complications?The eNOS signalosome and its link to endothelial dysfunction.Caveolin-1/-3: therapeutic targets for myocardial ischemia/reperfusion injury.Caveolins and caveolae in ocular physiology and pathophysiology.Caveolin 1 and G-Protein-Coupled Receptor Kinase-2 Coregulate Endothelial Nitric Oxide Synthase Activity in Sinusoidal Endothelial Cells.Caveolin-1 in the Pathogenesis of Diabetic Nephropathy: Potential Therapeutic Target?Knock down of caveolin-1 affects morphological and functional hallmarks of human endothelial cells.Contemporary Approaches to Modulating the Nitric Oxide-cGMP Pathway in Cardiovascular Disease.Deciphering the binding of caveolin-1 to client protein endothelial nitric-oxide synthase (eNOS): scaffolding subdomain identification, interaction modeling, and biological significance.Improving the Outcome of Vein Grafts: Should Vascular Surgeons Turn Veins into Arteries?A new approach to weight loss: just activate endothelial NO synthase!The Role of Nitroglycerin and Other Nitrogen Oxides in Cardiovascular Therapeutics.Caveolin-1 deficiency protects against mesangial matrix expansion in a mouse model of type 1 diabetic nephropathy.Growth differentiation factor 15 impairs aortic contractile and relaxing function through altered caveolar signaling of the endothelium.

P2860

Q21129237-26BC00A5-74B9-44C6-B1FD-19958FE3F066 Q24300536-B04D62B3-F6FB-4AB7-A572-A5B559BF71B3 Q27004401-80F0B844-E36D-4DEA-AF48-7629B130C6B7 Q27315127-43D8106A-4135-4FC4-9E7F-FB2360ADC511 Q30275542-307A9B07-0FF2-4629-9E8C-95506C641F0B Q30278654-B5D4374A-B912-439E-B7D0-7D995F65A69A Q30406156-C8E91987-A8AB-496D-B965-C8AF53D4B4B5 Q30524349-DAB331EC-8126-4653-9854-E0897DF26F96 Q34341970-78D77A04-4D0B-44A4-9E78-67D4F0399F80 Q34674311-4D2D168F-C16B-4355-9458-1771A4082AE7 Q35208361-6DDAC2E8-F0AC-46AD-956D-6182F1F2FB01 Q35656478-7E692520-0B0E-4D5C-B596-56D5DEA7CAA1 Q35861809-E905D049-0D52-4803-8D52-268FA82521B9 Q36010112-9C42F299-9E1F-4D5B-B65B-F0F0F71D58B0 Q36186312-941B374E-24A1-4C95-BE50-D67DAA14B0FB Q36193737-2F981B36-E094-4163-B0B7-4733AA04BF1A Q37362387-512B61B4-18D2-4AFC-8E03-48B511DD6614 Q37481098-44110037-BE81-4C94-91F7-C438B5EFE953 Q37516872-15B85AC8-BBA8-494F-B115-7D3CE9034E4D Q37589401-58EE5687-70C8-48AC-A116-05DE08CCDC81 Q37643632-123B2A38-396A-45DB-BC5C-A3900C469373 Q37660941-ABD5903F-FB4E-419F-9E5F-54BF6410F9B4 Q37947602-AD283CAF-C1A7-4375-B5FC-4FF3E74E5E81 Q38197315-F34F227A-0D5C-4E70-B96D-167627B0A9C7 Q38254908-B7B7CD94-2D77-4C6D-82B9-086F43EA2E75 Q38423887-30DE3A3F-E9B3-40F3-8F6F-091D9A4DC073 Q38451253-999258E2-2185-4716-BF17-B557872775ED Q38835675-253C7353-E8D9-48E5-81BE-1EDDF806E6AC Q38855645-09AD2C60-FF6C-4EE9-8309-BCACE805B5B6 Q38963501-4F5771A9-6F2C-476D-89A3-B281D2561AD1 Q38978258-0F4A786D-E7E9-4053-8AE3-B88C0E4A62B7 Q39173742-A034C362-6469-4D76-97B0-AA960BAD080C Q39184910-E39A5F22-8BBA-41F9-B249-EB0D50A5FF65 Q39209626-EC504AC8-A2C4-4124-9C95-4C728A1AA3EC Q39999567-7692A474-F791-4C1D-BD29-C95CE369A294 Q42352727-A3295AFD-67D1-4BEA-A63D-A24D4642B034 Q43103448-97C419B3-7A39-4C4D-87C6-E499BE47BD09 Q47667272-2BFF0000-EA1B-4EEC-B1DA-1A58C2E85BA3 Q50884558-7C859347-AF82-480C-89E1-57CE8A348547 Q52632771-EAA5BCE7-440F-44B4-8DBC-7A30B8BBBE3D

P2860

A noninhibitory mutant of the caveolin-1 scaffolding domain enhances eNOS-derived NO synthesis and vasodilation in mice.

http://www.wikidata.org/entity/Q35187037

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

A noninhibitory mutant of the ...... esis and vasodilation in mice.

@ast

A noninhibitory mutant of the ...... esis and vasodilation in mice.

@en

type

label

A noninhibitory mutant of the ...... esis and vasodilation in mice.

@ast

A noninhibitory mutant of the ...... esis and vasodilation in mice.

@en

prefLabel

A noninhibitory mutant of the ...... esis and vasodilation in mice.

@ast

A noninhibitory mutant of the ...... esis and vasodilation in mice.

@en

P1433

Q35187037-2A5ADF10-FD75-4367-BFD0-F895921641B7

P1476

Q35187037-EE652BF1-55CB-4351-8FCB-407E0E5BA740

P2093

Q35187037-08EC1C50-D35D-4BC8-87C2-DC0295975D1F

Q35187037-0BAFDA5A-9DC3-4ED1-A161-7A8BA1A99D38

Q35187037-0E14B0B6-80D0-41C1-815E-803DE5CD7A32

Q35187037-1654F1FE-40DA-467C-A7C6-73CF69108321

Q35187037-BC8DB479-881F-437C-BDF1-D984E39B6FE5

P2860

Q35187037-14A45336-E893-4A49-9E25-8DDE68044813

Q35187037-1FF5E010-5F05-4E63-BF96-80911B18807A

Q35187037-2BF18A6E-139A-457A-AC56-DC4AB5B5F89C

Q35187037-384C09A8-82AF-4D3F-BC49-B03E6B930130

Q35187037-3B11759F-78BC-4665-AF2D-8BB11E6CBAA0

Q35187037-3D204C8D-8DE4-4CAE-87C6-3FBFB5599619

Q35187037-3F64F3D6-3613-4D0F-AD04-310332A8F3A6

Q35187037-4F4936D3-F670-41FB-8A52-B8DCD248B1BF

Q35187037-50B9AF38-79AE-430B-95C3-73B48CE77EBA

Q35187037-69EC4CA0-4982-47D1-88D0-83B2868F9172

P304

Q35187037-8BBE24E0-F6C2-4BE9-9B73-10AC9657CAA1

P31

Q35187037-C0A91668-73AC-43A6-8A43-1BE5DCC0934C

P356

Q35187037-04488E8D-F95E-4122-935A-124B7B207971

P407

Q35187037-F994699E-718B-44CD-9C61-3F854B99B88C

P433

Q35187037-C3B41E76-9568-44D0-9759-DE700D9B93D3

P478

Q35187037-EEA64D11-2DFA-4867-88F4-844B86A43A07

P577

Q35187037-0AF99BAB-A095-43BE-B068-E2890AE3335F

P5875

Q35187037-4B7F822F-ACB8-4BBE-B07E-FA8C6F60BC45

P698

Q35187037-20AB3E87-FAF1-47E8-BCCB-3BC0011068EB

P932

Q35187037-2DF9A8C9-3932-4B63-B650-E13348E8687D

P356

P1433

Journal of Clinical Investigation

P1476

A noninhibitory mutant of the ...... esis and vasodilation in mice.

@en

P2093

Arpeeta Sharma

http://www.w3.org/2001/XMLSchema#string

Ethan Marin

http://www.w3.org/2001/XMLSchema#string

Pascal Bernatchez

http://www.w3.org/2001/XMLSchema#string

Philip M Bauer

http://www.w3.org/2001/XMLSchema#string

William C Sessa

http://www.w3.org/2001/XMLSchema#string

P2860

Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity

Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins

Nitric oxide synthases are crucially involved in the development of the severe cardiomyopathy of caveolin-1 knockout mice

Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling

Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+-calmodulin and caveolin

Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo

Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice

The multiple faces of caveolae

Endothelial caveolin-1 regulates pathologic angiogenesis in a mouse model of colitis.

Endothelial-specific expression of caveolin-1 impairs microvascular permeability and angiogenesis.

P304

3747-3755

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI44778

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51535449

http://www.w3.org/2001/XMLSchema#string

P698

21804187

http://www.w3.org/2001/XMLSchema#string

P932

3163946

http://www.w3.org/2001/XMLSchema#string